Early Initiation of Antitumor Necrosis Factor Therapy Reduces Postoperative Recurrence of Crohn's Disease Following Ileocecal Resection.
Jordan E AxelradTerry LiSalam P BachourTakahiro I NakamuraRavi ShahMichael C SachsShannon ChangDavid P HudesmanStefan D HolubarAmy L LightnerEdward L BarnesBenjamin L CohenFlorian RiederEren EsenFeza RemziMiguel RegueiroBenjamin ClickPublished in: Inflammatory bowel diseases (2022)
Early initiation of an anti-TNF agent within 4 weeks following an ICR was associated with a reduction in POR. Vedolizumab or ustekinumab, at any time following surgery, was not associated with a reduction in POR, although sample size was limited.